According to Zhitong Finance App, China Resources Pharmaceutical (03320) announced that China Resources Pharmaceutical Holdings Co., Ltd. (China Resources Pharmaceutical Holdings), a wholly-owned subsidiary of the company, has completed the public offering of the second 2026 corporate bonds in China. The second 2026 corporate bond with a principal amount of RMB 900 million has been issued, with a term of three years and an annual coupon interest rate of 1.48%.

The net proceeds raised from the issuance of the second 2026 corporate bond issue will be used for productive expenses, including repayment of corporate debt, supplementary working capital, project development and operating expenses, investments related to scientific and technological innovation, and other purposes in accordance with applicable laws and regulations.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.